Related references
Note: Only part of the references are listed.Biochanin A induces a brown-fat phenotype via improvement of mitochondrial biogenesis and activation ofAMPKsignaling in murineC3H10T1/2 mesenchymal stem cells
Md. Shamim Rahman et al.
PHYTOTHERAPY RESEARCH (2021)
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance
Anil Kumar et al.
NATURE COMMUNICATIONS (2021)
LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH
Noboru Takata et al.
SCIENTIFIC REPORTS (2021)
FGF21 promotes non-small cell lung cancer progression by SIRT1/PI3K/AKT signaling
Xiaofeng Yu et al.
LIFE SCIENCES (2021)
Leukocyte cell-derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT-1 pathway in mice
Jinghua Wang et al.
LIVER INTERNATIONAL (2021)
Increase in PPARγ inhibitory phosphorylation by Fetuin-A through the activation of Ras-MEK-ERK pathway causes insulin resistance
Snehasis Das et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K-Akt-mTOR signaling pathway
Han Dai et al.
CELL DEATH & DISEASE (2021)
Brown and beige adipose tissue regulate systemic metabolism through a metabolite interorgan signaling axis
Anna Whitehead et al.
NATURE COMMUNICATIONS (2021)
Variable Changes of Circulating ANGPTL3 and ANGPTL4 in Different Obese Phenotypes: Relationship with Vasodilator Dysfunction
Francesca Schinzari et al.
BIOMEDICINES (2021)
Circulating Fibroblast Growth Factor-21 and Risk of Metachronous Colorectal Adenoma
Ana Florea et al.
JOURNAL OF GASTROINTESTINAL CANCER (2021)
S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development
Cyril Sobolewski et al.
GUT (2020)
Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity
Ji A. Seo et al.
NATURE COMMUNICATIONS (2020)
Adipogenesis: A Complex Interplay of Multiple Molecular Determinants and Pathways
Melvin A. Ambele et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma
Chuanzong Zhao et al.
CELL COMMUNICATION AND SIGNALING (2020)
Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase
Ilaria Barchetta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling
Qianqian Zheng et al.
THERANOSTICS (2020)
Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma
Antoine L'Hermitte et al.
HEPATOLOGY (2019)
Fetuin-A modulates lipid mobilization in bovine adipose tissue by enhancing lipogenic activity of adipocytes
Clarissa Strieder-Barboza et al.
JOURNAL OF DAIRY SCIENCE (2019)
An ANGPTL4-ceramide-protein kinase C axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice
Tzu-Chieh Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet
Yongde Luo et al.
GASTROENTEROLOGY (2019)
LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis
Meng Xu et al.
CELL (2019)
Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer
Yea Eun Kang et al.
CANCERS (2019)
Two-hundred-liter scale fermentation, purification of recombinant human fibroblast growth factor-21, and its anti-diabetic effects on ob/ob mice
Qi Hui et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)
PGC-1 activation: a therapeutic target for type 2 diabetes?
Daixiu Yuan et al.
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY (2019)
A role for phosphatidylcholine and phosphatidylethanolamine in hepatic insulin signaling
Jelske N. van der Veen et al.
FASEB JOURNAL (2019)
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Reenam S. Khan et al.
HEPATOLOGY (2019)
Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study
Edgar D. Charles et al.
OBESITY (2019)
The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis
Mathilde Mouchiroud et al.
MOLECULAR METABOLISM (2019)
Metabolic adaptation and maladaptation in adipose tissue
Edward T. Chouchani et al.
NATURE METABOLISM (2019)
The implication of hepatokines in metabolic syndrome
Maryam Esfahani et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis
Mathilde Mouchiroud et al.
JCI INSIGHT (2019)
The hepatokine Tsukushi gates energy expenditure via brown fat sympathetic innervation
Qiuyu Wang et al.
NATURE METABOLISM (2019)
The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans
Andreas Peter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota
Aafke W. F. Janssen et al.
DIABETOLOGIA (2018)
LECT2 promotes inflammation and insulin resistance in adipocytes via P38 pathways
Tae Woo Jung et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Identification of chromatin-accessible domains in non-alcoholic steatohepatitis-derived hepatocellular carcinoma
Mekonnen L. Dechassa et al.
MOLECULAR CARCINOGENESIS (2018)
Plasma ANGPTL-4 is Associated with Obesity and Glucose Tolerance: Cross-Sectional and Longitudinal Findings
Silvia Barja-Fernandez et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
Jasmine Chong et al.
NUCLEIC ACIDS RESEARCH (2018)
Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease
V. Pampanini et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2018)
INTERORGAN METABOLIC CROSSTALK IN HUMAN INSULIN RESISTANCE
Sofiya Gancheva et al.
PHYSIOLOGICAL REVIEWS (2018)
Brown adipose tissue derived ANGPTL4 controls glucose and lipid metabolism and regulates thermogenesis
Abhishek K. Singh et al.
MOLECULAR METABOLISM (2018)
Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet
Garima Singhal et al.
MOLECULAR METABOLISM (2018)
Metabolites as regulators of insulin sensitivity and metabolism
Qin Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Quantitative screening of serum protein biomarkers by reverse phase protein arrays
Zhizhou Kuang et al.
Oncotarget (2018)
Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis
Binod Aryal et al.
JCI INSIGHT (2018)
PTEN Down-Regulation Promotes β-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice
Ekaterina Kachaylo et al.
HEPATOLOGY (2017)
Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes
Xianlong Ye et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases
Liang Wu et al.
SCIENTIFIC REPORTS (2017)
BMP4 Gene Therapy in Mature Mice Reduces BAT Activation but Protects from Obesity by Browning Subcutaneous Adipose Tissue
Jenny M. Hoffmann et al.
CELL REPORTS (2017)
Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis
Hye Jin Yoo et al.
PLOS ONE (2017)
Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma
Amal S. El-Shal et al.
CYTOKINE (2017)
Visceral and subcutaneous adipose tissue express and secrete functional alpha2hsglycoprotein (fetuin a) especially in obesity
Diego Perez-Sotelo et al.
ENDOCRINE (2017)
Fetuin-A downregulates adiponectin through Wnt-PPARγ pathway in lipid induced inflamed adipocyte
Soumik Agarwal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
Saswata Talukdar et al.
CELL METABOLISM (2016)
The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases
Li Li et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes
Hung-Tsung Wu et al.
DIABETOLOGIA (2016)
Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption
Nicolas Calo et al.
GUT (2016)
Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21
Eun Kyung Kim et al.
MEDIATORS OF INFLAMMATION (2016)
Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease
Andrea Sanchez-Pareja et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis
Kyung Mook Choi
ENDOCRINOLOGY AND METABOLISM (2016)
Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles
Ja Young Jeon et al.
ENDOCRINE (2016)
A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression
Hwan-Jin Hwang et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism
Ruth C. Meex et al.
CELL METABOLISM (2015)
Comparison of PEGylated FGF-21 with insulin glargine for long-lasting hypoglycaemic effect in db/db mice
X. Ye et al.
DIABETES & METABOLISM (2015)
Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1α pathway
Kunqian Ji et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Phosphatidylinositol 3-kinase (PI3K) signalling regulates insulin-like-growth factor binding protein-2 (IGFBP-2) production in human adipocytes
Franziska Wilhelm et al.
GROWTH HORMONE & IGF RESEARCH (2015)
Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice
Marion Peyrou et al.
JOURNAL OF HEPATOLOGY (2015)
A study of genes involved in adipocyte differentiation
Shunming Zhu et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2015)
Obesity and diabetes: the link between adipose tissue dysfunction and glucose homeostasis
Monise Viana Abranches et al.
NUTRITION RESEARCH REVIEWS (2015)
A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines
Yi Xiang et al.
ONCOLOGY REPORTS (2015)
Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus
Tamer Ahmed Ismail et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
miR-140-5p regulates adipocyte differentiation by targeting transforming growth factor-β signaling
Xin Zhang et al.
SCIENTIFIC REPORTS (2015)
Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance
Su Gao et al.
MOLECULAR METABOLISM (2015)
Hepatokines as a Link between Obesity and Cardiovascular Diseases
Hye Jin Yoo et al.
DIABETES & METABOLISM JOURNAL (2015)
Comparative effects of metformin and pioglitazone on fetuin-A and osteoprotegerin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial
Alireza Esteghamati et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2015)
BMP4 and BMP7 induce the white-to-brown transition of primary human adipose stem cells
Manuela Elsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin Resistance
Fei Lan et al.
DIABETES (2014)
PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis
Xuehui Hong et al.
GUT (2014)
Leukocyte Cell-Derived Chemotaxin 2 Antagonizes MET Receptor Activation to Suppress Hepatocellular Carcinoma Vascular Invasion by Protein Tyrosine Phosphatase 1B Recruitment
Chi-Kuan Chen et al.
HEPATOLOGY (2014)
Inflammatory and Metabolic Biomarkers and Risk of Liver and Biliary Tract Cancer
Krasimira Aleksandrova et al.
HEPATOLOGY (2014)
DNA microarray analysis of genes differentially expressed in adipocyte differentiation
Chunyan Yin et al.
JOURNAL OF BIOSCIENCES (2014)
Interplay between FGF21 and insulin action in the liver regulates metabolism
Brice Emanuelli et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Acute-Phase Protein α1-Antitrypsin-A Novel Regulator of Angiopoietin-like Protein 4 Transcription and Secretion
Eileen Frenzel et al.
JOURNAL OF IMMUNOLOGY (2014)
Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma
Kevin Tak-Pan Ng et al.
MOLECULAR CANCER (2014)
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Rachel J. Perry et al.
NATURE (2014)
Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression
Akinobu Ochi et al.
PLOS ONE (2014)
Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes
Paul Paolini et al.
PHARMACOGENOMICS (2014)
FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases
Nobuyuki Itoh
FRONTIERS IN ENDOCRINOLOGY (2014)
Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A
Tae Woo Jung et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
Chaofeng Yang et al.
BMC GASTROENTEROLOGY (2013)
Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
Zhuofeng Lin et al.
CELL METABOLISM (2013)
An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
William L. Holland et al.
CELL METABOLISM (2013)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
Fibroblast Growth Factor 21 Improves Insulin Resistance and Ameliorates Renal Injury in db/db Mice
H. W. Kim et al.
ENDOCRINOLOGY (2013)
Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice
Joao Paulo G. Camporez et al.
ENDOCRINOLOGY (2013)
Adipocyte Fetuin-A Contributes to Macrophage Migration into Adipose Tissue and Polarization of Macrophages
Priyajit Chatterjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use
Sihao Liu et al.
NATURE (2013)
The role of hepatokines in metabolism
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver
Akinori Okumura et al.
BIOSCIENCE TRENDS (2013)
Evaluation of TGFβ, XPO4, elF5A2 and ANGPTL4 as biomarkers in HCC
Hao Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Defining the interorgan communication network: systemic coordination of organismal cellular processes under homeostasis and localized stress
Ilia A. Droujinine et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
Mechanisms of insulin resistance in obesity
Jianping Ye
FRONTIERS OF MEDICINE (2013)
Plasma mannose-binding lectin is stimulated by PPARα in humans
Maryam Rakhshandehroo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Long-Acting FGF21 Has Enhanced Efficacy in Diet-Induced Obese Mice and in Obese Rhesus Monkeys
Murielle M. Veniant et al.
ENDOCRINOLOGY (2012)
Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance
Clarence Hale et al.
ENDOCRINOLOGY (2012)
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
John Willy Haukeland et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Metformin Stimulates FGF21 Expression in Primary Hepatocytes
Eva B. Nygaard et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Angiopoietin-like 4 (Angptl4) Protein Is a Physiological Mediator of Intracellular Lipolysis in Murine Adipocytes
Nora E. Gray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
PTEN regulation of ERK1/2 signaling in cancer
Mahandranauth A. Chetram et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2012)
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Pontus Bostroem et al.
NATURE (2012)
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Durba Pal et al.
NATURE MEDICINE (2012)
Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-κB
Min Suk Lee et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Development of IGF Signaling Antibody Arrays for the Identification of Hepatocellular Carcinoma Biomarkers
Qi Zhou et al.
PLOS ONE (2012)
Thiazolidinediones Are Potent Inducers of Fibroblast Growth Factor 21 Expression in the Liver
Katsutaka Oishi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic target
H. T. Ong et al.
CANCER GENE THERAPY (2011)
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
Fredirick L. Mashili et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Hypoxia-Inducible Factor 1 Alpha-Activated Angiopoietin-Like Protein 4 Contributes to Tumor Metastasis via Vascular Cell Adhesion Molecule-1/Integrin β1 Signaling in Human Hepatocellular Carcinoma
Hong Li et al.
HEPATOLOGY (2011)
A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects
Jae Man Lee et al.
NATURE (2011)
Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat
Tim J. Schulz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Non-genomic loss of PTEN function in cancer: not in my genes
Nick R. Leslie et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Loss of function of PTEN alters the relationship between glucose concentration and cell proliferation, increases glycolysis, and sensitizes cells to 2-deoxyglucose
Marie-Jose Blouin et al.
CANCER LETTERS (2010)
A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance
Hirofumi Misu et al.
CELL METABOLISM (2010)
Hypothalamic Angptl4/Fiaf Is a Novel Regulator of Food Intake and Body Weight
Hyun-Kyong Kim et al.
DIABETES (2010)
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Ffolliott M. Fisher et al.
DIABETES (2010)
IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcription
Matei Mireuta et al.
GROWTH FACTORS (2010)
Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss
Johanna Maria Brix et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Relevant use of Klotho in FGF19 subfamily signaling system in vivo
Ken-ichi Tomiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models-association with liver and adipose tissue effects
Jing Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
PGC-1α-induced improvements in skeletal muscle metabolism and insulin sensitivity
Arend Bonen
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2009)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity
Eric D. Berglund et al.
ENDOCRINOLOGY (2009)
Enhanced angiogenesis in obesity and in response to PPARγ activators through adipocyte VEGF and ANGPTL4 production
Olga Gealekman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Transcriptional regulation of adipogenesis by KLF4
Kivanc Birsoy et al.
CELL METABOLISM (2008)
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coskun et al.
ENDOCRINOLOGY (2008)
FGF21 is an Akt-regulated myokine
Yasuhiro Izumiya et al.
FEBS LETTERS (2008)
PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappa Bp65/mTOR-dependent mechanism
Manlio Vinciguerra et al.
GASTROENTEROLOGY (2008)
Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus
Katsuhito Mori et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
Anita M. Hennige et al.
PLOS ONE (2008)
βKlotho is required for metabolic activity of fibroblast growth factor 21
Yasushi Ogawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K-Akt pathway activation in glioblastoma and prostate cancer
R. Mehrian-Shai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue
Valentina Sukonina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes
Tsutomu Yamada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans
N Stefan et al.
DIABETES CARE (2006)
The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity
S Mandard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang et al.
NATURE (2005)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Live-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity
B Stiles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment
S Mandard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of β-catenin in the liver
C Ovejero et al.
HEPATOLOGY (2004)
Elevated insulin, proinsulin and insulin-like growth factor-binding protein-1 in liver disease
DL Hwang et al.
GROWTH HORMONE & IGF RESEARCH (2003)
Pilot study of elevated levels of insulin-like growth factor-binding protein-2 as indicators of hepatocellular carcinoma
MB Ranke et al.
HORMONE RESEARCH (2003)
Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene
ST Mathews et al.
DIABETES (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Peroxisome proliferator-activated receptor γ target gene encoding a novel angiopoietin-related protein associated with adipose differentiation
JC Yoon et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
α2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor
ST Mathews et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)
Share Paper
